Background Epithelial cell adhesion molecule (EpCAM) is known to highly expression and
promotes cancer progression in many cancer types, including colorectal cancer. While …

Epithelial cell adhesion molecule (EpCAM) is highly expressed in colon cancers, but its role
in cancer progression remains to be elucidated. In this work, we found that the extracellular …

The epithelial cell adhesion molecule (EpCAM) is one of the most frequently and intensely
expressed of tumor-associated antigens, but the role that EpCAM plays in the proliferation …

Epithelial cell adhesion molecule (EpCAM) functions not only in physiological processes but
also participates in the development and progression of cancer. In recent decades …

Colorectal cancer (CRC) is one of the most common malignancies worldwide. In spite of
various attempts to ameliorate outcome by escalating treatment, significant improvement is …

Epithelial cell adhesion molecule (EpCAM) is a cell surface protein that was discovered as a
tumour marker of epithelial origins nearly four decades ago. EpCAM is expressed at basal …

Purpose Epithelial cellular adhesion molecule (EpCAM) is an attractive immunotherapeutic
target to overcome metastasis of a variety of epithelium-oriented cancers. Edrecolomab, one …

Epithelial cell adhesion molecule (EpCAM) is known to be overexpressed in epithelial
cancers associated with enhanced malignant potential, particularly colorectal carcinoma …

Initially discovered as a dominant antigen on colon carcinomas, the epithelial cell adhesion
molecule (EpCAM) was considered a mere cell adhesion molecule and reliable surface …

Purpose To identify the role of epithelial cellular adhesion molecule (EpCAM) in gastric
cancer growth and explore the potential value of EpCAM monoclonal antibody as new …